PS-002 clinical trials

PS-002 for the Treatment of IgA Nephropathy in Adults

This study investigates a new treatment, PS-002, for IgA nephropathy, a kidney condition. It's an early-stage trial looking at whether the treatment is safe, well-tolerated, and shows initial benefits in adults with the condition, particularly those at higher risk of their kidney disease getting worse.